Copyright
©The Author(s) 2022.
World J Diabetes. Nov 15, 2022; 13(11): 972-985
Published online Nov 15, 2022. doi: 10.4239/wjd.v13.i11.972
Published online Nov 15, 2022. doi: 10.4239/wjd.v13.i11.972
Figure 4 Dietary Nε-(carboxymethyl)lysine impairs glucose metabolism in mouse myocardium.
A and B: mRNA levels of glucose transporter (Glut)-1 and Glut-4 in the mouse myocardium; C-G: Western blotting and its relative quantification of Glut-1, Glut-4, phospho-Akt, and phospho-AMP-activated protein kinase (AMPK) in the mouse myocardium; H: Citrate synthase (CS) activity in the mouse myocardium. dCML: Dietary Nε-(carboxymethyl)lysine; Bcl-2: B-cell leukemia/lymphoma 2; BAX: Bcl-2-associated X; ANP: Atrial natriuretic peptide. n = 6. bP < 0.01, compared with the control (Ctrl) group.
- Citation: Wang ZQ, Sun Z. Dietary Nε-(carboxymethyl) lysine affects cardiac glucose metabolism and myocardial remodeling in mice. World J Diabetes 2022; 13(11): 972-985
- URL: https://www.wjgnet.com/1948-9358/full/v13/i11/972.htm
- DOI: https://dx.doi.org/10.4239/wjd.v13.i11.972